Table 5 Multivariate logistic regression results for CYP17A1 genotypes, testosterone and prostate cancer Risk.

From: Association between CYP17A1 and HSD3B1 gene polymorphisms and testosterone levels in Nigerian prostate cancer patients

 

Odds ratio (OR)

95% CI (lower–upper)

p-Value

CYP17A1 AA (Intercept)

17.46

2.45–124.66

0.004

CYP17A1 AG vs. AA

0.91

0.30–2.70

0.861

CYP17A1 GG vs. AA

0.39

0.07–2.07

0.266

Testosterone

0.83

0.73–0.94

0.003*

  1. CI , Confidence Interval; OR , Odds Ratio. Genotype AA serves as the reference group
  2. * indicates statistical significance at p < 0.05
Back to article page